Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › infliximab

infliximab

5 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of infliximab

55 trials tracked of infliximab: 28 in phase 3 or 4 and 10 with published results. The most-cited published study has 603 citations.

55Trials tracked
28Phase 3 & 4
0Recruiting
10With published results
Phase distribution
Phase 4 11 Phase 3 17 Phase 2 9 Other / NA 18
  1. Phase 4 Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery Completed · 603 cited
  2. Phase 3 A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3) Completed · 511 cited
  3. Phase 3 KIDCARE (Kawasaki Disease Comparative Effectiveness Trial) Completed · 112 cited
  4. Phase 3 A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors Completed · 94 cited
  5. Phase 3 Immune Modulators for Treating COVID-19 Completed · 68 cited
  6. Phase 4 Dynamics of Inflammation and Its Blockade on Motivational Circuitry in Depression Completed · 61 cited
Show 44 more trials
  1. Phase 3 A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). Completed · 59 cited
  2. Phase 3 Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab Completed · 20 cited
  3. Phase 3 MIS-C Comparative Effectiveness Study Completed · 6 cited
  4. Phase 4 Safety of Reduced Infliximab Infusion Time Completed
  5. Phase 4 Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab Completed
  6. Phase 4 A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL) Completed
  7. Phase 4 RESTART C0168Z05 Rheumatoid Arthritis Study Completed
  8. Phase 4 A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133) Completed
  9. Phase 4 Centocor Microarray Study of Patients Completed
  10. Phase 4 Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis Completed
  11. Phase 4 An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis Completed
  12. Phase 4 A Study of Infliximab for Treatment Resistant Major Depression Completed
  13. Phase 3 Safety and Efficacy of Infliximab in Palmoplantar Psoriasis Completed
  14. Phase 3 Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease Completed
  15. Phase 3 Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED) Completed
  16. Phase 3 Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED) Completed
  17. Phase 3 A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis Completed
  18. Phase 3 PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept Completed
  19. Phase 3 A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis Completed
  20. Phase 3 The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED) Completed
  21. Phase 3 Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) Completed
  22. Phase 3 A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612) Completed
  23. Phase 2 Use of Infliximab for the Treatment of Pemphigus Vulgaris Completed
  24. Phase 2 Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C Completed
  25. Phase 2 Effects of Inhibiting Early Inflammation in Kidney Transplant Patients Completed
  26. Phase 2 A Study to Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528) Completed
  27. Phase 2 A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19). Completed
  28. Phase 2 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression Completed
  29. Phase 2 An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis Completed
  30. Phase 2 Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL) Completed
  31. Phase 2 A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136) Completed
  32. N/A Real Life Dosing of Remicade for Rheumatoid Arthritis in Austria Monitored Over 9 Infusions (Study P03756)(COMPLETED) Completed
  33. N/A Remicade Safety Line (Study P03236)(COMPLETED) Completed
  34. N/A Biomarkers of Anti-TNF Treatment in Inflammatory Bowel Disease (IBD) Completed
  35. N/A Remicade Safety Line (Ankylosing Spondylitis)(Study P03275)(COMPLETED) Completed
  36. N/A Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) Completed
  37. N/A Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143) Completed
  38. N/A Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED) Completed
  39. N/A An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy Completed
  40. N/A Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED) Completed
  41. N/A A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417) Completed
  42. N/A European Safety Registry in Ulcerative Colitis (P04808) Completed
  43. N/A Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED) Completed
  44. N/A Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047) Completed

Showing the 50 most-cited and recently-updated of 55 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Combination therapies with adalimumab, infliximab, tofacitinib, or upadacitinib increase serious infection risk in rheumatoid arthritis
Rheumatology Sys. Review
Combination therapies with adalimumab, infliximab, tofacitinib, or upadacitinib increase serious infection risk in rheumatoid arthritis New data shows infection risks for rheumatoid arthritis treatments
This meta-analysis of 55,749 patients with rheumatoid arthritis found that while b/tsDMARD monotherapy carries a similar risk of serious inf…
New research highlights how combining certain medications for rheumatoid arthritis can increase the risk of serious infections.
Jul 18, 2026
Infliximab treatment achieved clinical remission in a pediatric patient with autoinflammation with infantile enterocolitis
Pediatrics Sys. Review
Infliximab treatment achieved clinical remission in a pediatric patient with autoinflammation with infantile enterocolitis Infliximab Shows Promise for Rare Infantile Bowel Disease
This case report and literature review describes a 2-year-and-4-month-old female with autoinflammation with infantile enterocolitis who achi…
A toddler with a rare genetic bowel disease achieved remission after treatment with infliximab, a drug used for other inflammatory condition…
Frontiers Jul 17, 2026
Infliximab may offer clinical improvement and wound reduction in non-Crohn's disease related fistulas
Gastroenterology Sys. Review
Infliximab may offer clinical improvement and wound reduction in non-Crohn's disease related fistulas Infliximab shows promise for complex fistulas in prostate cancer patients
This case report and mini-review describes a 76-year-old man with prostate cancer and non-Crohn's disease related fistulas treated with infl…
A new case report suggests that the drug infliximab may help treat difficult fistulas in men with a history of prostate cancer.
Frontiers Jun 16, 2026
Biosimilar switching maintains disease control in stable ankylosing spondylitis patients
Drug Pipeline RCT
Biosimilar switching maintains disease control in stable ankylosing spondylitis patients Cheaper Arthritis Drugs Work Just as Well
This structured narrative review of patients with stable ankylosing spondylitis found that switching from reference biologics to biosimilars…
Switching to cheaper arthritis drugs keeps patients just as healthy while cutting treatment costs in half without losing results.
Frontiers Apr 19, 2026
Infliximab in IVIG-resistant Kawasaki disease with cholestatic hepatitis: case report
Pediatrics RCT
Infliximab in IVIG-resistant Kawasaki disease with cholestatic hepatitis: case report Can a new drug stop heart damage in Kawasaki disease when standard treatments fail?
A case report describes a 2-year-old Han Chinese male with IVIG-resistant Kawasaki disease and cholestatic hepatitis treated with infliximab…
In a two-year-old boy with Kawasaki disease, the drug infliximab quickly stopped his fever and liver trouble, yet his heart artery damage ke…
Frontiers Apr 16, 2026